Red Tortoise »

Keros Therapeutics shares owned by Red Tortoise

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Red Tortoise from 13F filings

Historical chart of Red Tortoise investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Red Tortoise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Red Tortoise

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1k 56 20.36
2025-09-30 $2.3k 146 15.82
2025-06-30 $1.9k 146 13.35

More positions owned by Red Tortoise

Schwab International Equity Etf Etf (SCHF)
Schwab Fundamental International Equity Etf Etf (FNDF)
Ishares Core S&p 500 Etf Etf (IVV)
Schwab Emerging Markets Equity Etf Etf (SCHE)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Long-term Treasury Etf Etf (VGLT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Schwab Fundamental U.s. Large Company Etf Etf (FNDX)
Ishares Russell 1000 Value Etf Etf (IWD)
Schwab Short-term Us Treasury Etf Etf (SCHO)
Vanguard Value Etf Etf (VTV)
Ishares Core Dividend Growth Etf Etf (DGRO)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)

View all positions for Red Tortoise

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics